Kreos Capital
Venture debtLondon · Series A–Late Stage · 43 people tracked
Also known as KREOS CAPITAL GROUP LIMITED · KREOS CAPITAL GROUP V LIMITED · KREOS CAPITAL GROUP VI L.P. · KREOS CAPITAL GROUP VII LP
Investment thesis
Kreos Capital pioneered growth debt financing in Europe and Israel, providing tailored, flexible debt facilities to high-growth technology and healthcare companies. Since 1998 it has committed over EUR 7.0 billion across 830+ transactions to more than 640 companies, deploying more than EUR 800m annually. In technology it backs fintech, enterprise software, cybersecurity, semiconductors, digital marketing and AI companies; in healthcare it funds drug and treatment development, medical products and devices, and healthcare tech. Kreos supports companies through every stage of growth, from entry-level and mid-stage development through to late-stage, pre-IPO/exit, and publicly listed growth funding. Backed by institutional investors, it emphasizes long-term partnership with management teams and equity sponsors.
Source: firm website, verified Aug 25, 2026.
Team · 43 people
from the firm's website & public directories
What they invest in
from 8 of 8 portfolio companiesBiotech ×4Healthtech ×4E-commerce ×2Cloud Computing ×1Consumer ×1Data & Infrastructure ×1Direct to Consumer ×1Enterprise Software ×1
HQs:United States×2Belgium×1Germany×1Japan×1
Investments · 8 tracked
founders shown can be your intro pathBy year:2023 · 12017 · 12 dated
Sequana Medical develops the alfapump system and DSR therapy for treating fluid overload in patients with conditions such as liver disease and heart failure.
BiotechHealthtechMedical DevicesGhent, BE
Co-investorsNewton BiocapitalBlackRockEQT Life SciencesRosetta Capital Ltd.VI PartnersBootstrap Europe+2 more
Calliditas develops novel therapeutics for orphan indications, with an initial focus on renal and hepatic rare diseases.
BiotechHealthtech
Co-investorsIndustrifondenSofinnova Partners
Crescendo Biologics develops T cell enhancing therapeutics for immuno-oncology, based on its Humabody platform, with clinical candidates including the bispecific CB307 and immune cell engager CB699.
BiotechHealthtech
Co-investorsAndera PartnersAstellas Venture Management LLCEMBL VenturesFuture Planet CapitalQuan CapitalSofinnova Partners+1 more
Laminate provides physical card design, manufacturing, and fulfillment services for debit and credit card issuers, integrating with existing card issuing infrastructure.
FintechNew York City, US
Khurram Aslam(Founder)in
Co-investorsY Combinator
Marley Spoon is a meal kit delivery service that provides fresh food and recipes to consumers.
Direct to ConsumerE-commerceFoodTechBerlin, DE
Fabian Siegel(Founder & CEO)inJennifer Bernstein(Chief Financial Officer)Daniel Raab(Chief Operations Officer)Katalin Fritz(Chief Customer Officer)Nasreen Abdujaleel(Chief Technology Officer)Federico Rossi(Chief Marketing Officer)
Co-investorsLifeX VenturesPoint NineRunway Growth CapitalUnion Square Ventures (USV)VNV GlobalWestTech Ventures+4 more
Mixtiles creates magnetic picture frames and wall art products that can be easily repositioned without damaging walls, featuring museum-quality printing and customizable sizes and materials.
ConsumerE-commerceRetail Tech
Eytan Levit(Founder)in
Co-investors83NorthGreenfield PartnersC4 Ventures
MariaDB develops a relational database system designed to serve as a cost-effective alternative to legacy databases like Oracle for storing and accessing data across mobile, web, and IoT applications.
Cloud ComputingData & InfrastructureEnterprise SoftwareSilicon Valley, US
Vikas Mathur(Chief Product Officer)
Co-investorsHighBar PartnersOpenOceanSmartFinSpintop Ventures
Takeda is a global pharmaceutical company that develops medicines and treatments for patients, focused on advancing science, technology, and partnerships to create new standards of care.
BiotechHealthtechTokyo, JP
Claudia D'Augusta(Executive Officer)Eduardo Bravo Fernandez de Araoz(Executive Officer, Director)Marie Paule Richard(Executive Officer)Wilfried Dalemans(Executive Officer)
BoardJune Almenoff(Director)Russell Greig(Director)
Co-investorsKleiner PerkinsRho VenturesYsios Capital
Portfolio news
latest coverage across their companiesMixtiles · calcalistech.com · Jul 28, 2025
Frequently asked questions
- What stage does Kreos Capital invest at?
- Kreos Capital invests at the Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Kreos Capital focus on?
- Kreos Capital focuses on AI & Machine Learning, Biotech, Crypto & Web3, Cybersecurity, Enterprise Software, Fintech, Healthtech, Medical Devices, Sector Agnostic, Semiconductors.
- Where is Kreos Capital located?
- Kreos Capital is headquartered in London, GB.
Media · Podcasts & interviews
featuring the team"Mai no ha estat tan fàcil engegar projectes" Ross Ahlgren - Kreos Capital
ACCIÓ · Ross Ahlgren
"Les empreses catalanes han de pensar globalment" Ross Ahlgren - Kreos Capital
ACCIÓ · Ross Ahlgren
Co-investors · 4
Felix Capital is a venture capital firm operating at the intersection of technology and creativity, focusing on the evolution of the human experience at home, at work, and in-between.
White Star Capital is a multi-market venture capital firm with a presence across North America, Europe, and Asia, partnering with founders building globally minded technology businesses.
Octopus Ventures is a founder-focused European venture capital firm that backs mission-driven startups across seven core sectors, investing from idea stage through growth with a focus on pre-seed to Series A.
Glilot Capital Partners is an Israel-based venture capital firm focused on cybersecurity and AI, supporting founders from seed through growth via a multi-program framework (G-Seed, G+, Mach5, G-Club).
Firms observed investing alongside Kreos Capital, from public investor directories. Shared companies are the overlap with Kreos Capital's recorded portfolio.
Similar investors
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.